Csenge Advisory Group’s Oscar Health OSCR Stock Holding History

Csenge Advisory Group’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,753	Closed	-$428K	–	794
2025 Q4	$428K	Buy	+29,753	New	+$515K	0.02%	473

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Csenge Advisory Group's OSCR Position: Q1 2026 in Review

Csenge Advisory Group sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 29,753 shares — an estimated $428K sold.

Csenge Advisory Group first reported a position in OSCR in Q4 2025 and held it in 1 quarter. The position peaked at $428K in Q4 2025. 333 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

Csenge Advisory Group reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
Csenge Advisory Group sold 29,753 Oscar Health shares in Q1 2026, an estimated $428K.
Csenge Advisory Group first reported a position in Oscar Health in Q4 2025 and held it in 1 quarter.
Csenge Advisory Group's Oscar Health position peaked at $428K in Q4 2025.
333 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.